No photo of Daniel Batlle

View Scopus Profile

Daniel Batlle

  • 9691 Citations
1978 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Daniel Batlle MD is the Earle, del Greco, Levin Professor of Medicine at Northwestern University. He has been a Professor of Medicine at Northwestern and past Division Chief for 18 years . His clinical and research interests include acid-base disturbances, electrolyte disorders, hypertension, and diabetic nephropathy. Bench research currently involves the study of the renin angiotensin system and enzymes that degrade angiotensin 2 such as ACE2 and its potential therapeutic use.

Certifications and Licenses

Internal Medicine
Nephrology

Training Experience

1976Internship, Saint John Hospital and Medical Center, Detroit, Michigan
1977Residency, Wayne State University
1979Fellowship, Univ. of Illinois Hospital

Education/Academic qualification

MD, University of Barcelona

… → 1973

Research interests

  • Hypertension
  • Kidney
  • Nephrology

Fingerprint Dive into the research topics where Daniel Batlle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

NCR-19-2039- Ammonium excretion in ZS-9 treated mice with CKD

Batlle, D. & Wysocki, J.

AstraZeneca Pharmaceuticals LP

5/26/20 → 5/31/21

Project: Research project

    • The Role of MicroRNAs in Corneal Epithelial Homeostasis

    Batlle, D., Lavker, R. M., Peng, H. & Thaxton, C. S.

    Kennedy Institute - National Eye Clinic

    7/1/19 → 7/31/23

    Project: Research project

    • PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D

    Batlle, D., Molitch, M. E. & Wallia, A.

    Joslin Diabetes Center, Inc., National Institute of Diabetes and Digestive and Kidney Diseases

    9/15/17 → 6/30/19

    Project: Research project

    • Prot #16244: A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicenter, Event-Driven Phase III Study to Investigate the Efficacy and Safety of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects

    Batlle, D., Wallia, A., Huang, W. & Molitch, M. E.

    Bayer HealthCare Pharmaceuticals, Inc.

    1/5/16 → 5/31/20

    Project: Research project

    Urinary Renin Angiotensin System in Diabetes

    Batlle, D., Molitch, M. E., Rademaker, A. W. & Wysocki, J.

    National Institute of Diabetes and Digestive and Kidney Diseases

    6/15/15 → 4/30/20

    Project: Research project

    • Research Output

    Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology

    COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group, Jul 1 2020, In : Journal of the American Society of Nephrology : JASN. 31, 7, p. 1380-1383 4 p.

    Research output: Contribution to journal › Review article

    Open Access
    10 Scopus citations

    Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent

    Serfozo, P., Wysocki, J., Gulua, G., Schulze, A., Ye, M., Liu, P., Jin, J., Bader, M., Myöhänen, T., García-Horsman, J. A. & Batlle, D., Jan 1 2020, In : Hypertension (Dallas, Tex. : 1979). 75, 1, p. 173-182 10 p.

    Research output: Contribution to journal › Article

    • 14 Scopus citations

    An update on ACE2 amplification and its therapeutic potential

    Marquez, A., Wysocki, J., Pandit, J. & Batlle, D., 2020, (Accepted/In press) In : Acta Physiologica.

    Research output: Contribution to journal › Review article

    Open Access

    • A Survey on Dialysis-Related Muscle Cramping and a Hypothesis of Angiotensin II on Its Pathophysiology

    Punj, S., Enaam, A., Marquez, A., Atkinson, A. J. & Batlle, D., Jun 2020, In : Kidney International Reports. 5, 6, p. 924-926 3 p.

    Research output: Contribution to journal › Article

    Open Access

    Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers

    Danser, A. H. J., Epstein, M. & Batlle, D., Jun 1 2020, In : Hypertension. p. 1382-1385 4 p.

    Research output: Contribution to journal › Review article

    Open Access
    • 82 Scopus citations